Want to join the conversation?
$HRS 4Q15 Q&A: Gautam from Cowen asked, does the guidance include sale synergies. Bill Brown said that the guidance does not include sales synergies. Right now, we're focused on the cost side there we got out of gauge very quickly, as we've talked before the deal was justified on cost savings not revenue upside.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?